Silence Therapeutics launches $150 million ADS public offering

RTTNews··GB·Read original
2▲2 ▼0Impact / 5
Summary · why it matters

Silence Therapeutics announced a proposed public offering of American Depositary Shares aiming to raise $150 million. Each ADS represents £0.05 of the company's capital. Underwriters will have a 30-day option to purchase an additional 15% of the ADSs at the offering price. Jefferies, Morgan Stanley, Cantor and William Blair are joint book-running managers for the deal.

Impact on assets 3

Financials▲ · 2 stocks
Morgan Stanley
MS
▲ PositiveCapitalrelevance

Morgan Stanley is a joint book-running manager for the offering, earning fees.

Health Care▲ · 1 stocks

Off-coverage companies 1

William Blair & CompanyPrivate▲ Positive
Capitalrelevance

William Blair is a joint book-running manager for the offering, earning fees.

© 2026 MarketIVNews